A phase I study of the combination of gemcitabine (G), vinorelbine (V) and cisplatin (P) in patients (pts) with solid tumors.

被引：0
|
作者：
Schrijvers, D [1 ]
Dyck, J [1 ]
Van den Brande, J [1 ]
Wilmes, P [1 ]
Korst, A [1 ]
Lardon, F [1 ]
Vermorken, J [1 ]
机构：
[1] Univ Antwerp Hosp, Dept Med Oncol, Edegem, Belgium
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
642P
引用
收藏
页码：140 / 140
页数：1
相关论文
共 50 条
  • [1] Phase I study of a 3-drug combination of gemcitabine, vinorelbine and cisplatin (GVP) in patients (PTS) with solid tumors
    Rasschaert, Marika A.
    Pauwels, Bea
    Corthouts, Bob
    Van den Brande, Jan
    Schrijvers, Dirk
    Vermorken, Jan B.
    ANNALS OF ONCOLOGY, 2006, 17 : 142 - 142
  • [2] Combination study of navitoclax with gemcitabine (G) in patients (pts) with solid tumors.
    Cleary, J. M.
    Lima, C. M. S. Rocha
    Hurwitz, H.
    Montero, A. J.
    Shapiro, G.
    Franklin, C.
    Yang, J.
    Graham, A. M.
    Busman, T.
    Mabry, M.
    Holen, K. D.
    Krivoshik, A.
    Humerickhouse, R.
    Uronis, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] Combination Chemotherapy of Vinorelbine and Cisplatin: A Phase I Pharmacokinetic Study in Patients with Metastatic Solid Tumors
    Delord, Jean-Pierre
    Puozzo, Christian
    Lefresne, Florence
    Bugat, Roland
    ANTICANCER RESEARCH, 2009, 29 (02) : 553 - 560
  • [4] Phase I dose-finding study of trabectedin (T) in combination with cisplatin (C) in patients (pts) with advanced solid tumors.
    Sessa, C.
    Gallerani, E.
    Del Conte, G.
    Christinat, A.
    Perotti, A.
    Lardelli, P.
    Kahatt, C. M.
    Florez, A.
    Fernandez, C.
    Miani, M.
    Gianni, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] A Phase I Combination Study of Olaparib with Cisplatin and Gemcitabine in Adults with Solid Tumors
    Rajan, Arun
    Carter, Corey A.
    Kelly, Ronan J.
    Gutierrez, Martin
    Kummar, Shivaani
    Szabo, Eva
    Yancey, Mary Ann
    Ji, Jiuping
    Mannargudi, Baskar
    Woo, Sukyung
    Spencer, Shawn
    Figg, William Douglas
    Giaccone, Giuseppe
    CLINICAL CANCER RESEARCH, 2012, 18 (08) : 2344 - 2351
  • [6] Phase I dose-escalation study of AZD7762 in combination with gemcitabine (gem) in patients (pts) with advanced solid tumors.
    Sausville, E. A.
    LoRusso, P.
    Carducci, M. A.
    Barker, P. N.
    Agbo, F.
    Oakes, P.
    Senderowicz, A. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] A phase I study sunitinib malate (S) and gemcitabine (G) in solid tumors.
    Krishnamurthi, S. S.
    Rath, L.
    Bokar, J. A.
    Dowlati, A.
    Savvides, P.
    Gibbons, J.
    Cooney, M. M.
    Meropol, N. J.
    Ivy, S. P.
    Brell, J. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] A phase I dose-finding study of sunitinib (SU) in combination with gemcitabine (G) in patients (pts) with advanced solid tumors
    Michaelson, M. D.
    Schwarzberg, A.
    Ryan, D. P.
    McDermott, D. F.
    Shapiro, G. I.
    Tye, L.
    Chen, I.
    Selaru, P.
    Wang, E.
    Zhu, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] A PHASE I DOSE-FINDING STUDY OF SUNITINIB (SU) IN COMBINATION WITH GEMCITABINE (G) IN PATIENTS (PTS) WITH ADVANCED SOLID TUMORS
    Michaelson, M. D.
    Schwarzberg, A.
    Ryan, D.
    McDermott, D.
    Shapiro, G. I.
    Tye, L.
    Chen, I.
    Selaru, P.
    Wang, E.
    Zhu, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 156 - 156
  • [10] A phase I study of MK-2206 in combination with lapatinib in patients (pts) with advanced solid tumors.
    Wisinski, Kari Braun
    Tevaarwerk, Amye
    Bell, Maria
    Burkard, Mark E.
    Eickhoff, Jens C.
    Wilding, George
    LoConte, Noelle K.
    Traynor, Anne M.
    Hoang, Tien
    Heideman, Jennifer
    Kolesar, Jill
    Liu, Glenn
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345